ABOUT THE OPUS CLINICAL STUDY

In the OPUS clinical study, a new investigational drug called cenerimod is being tested. Cenerimod is a tablet taken once per day, which works by keeping lymphocytes in the lymph nodes and reducing inflammation, so stopping the immune system from attacking your body.10,11,12